Crescendo Biologics develops potent, multi-functional Humabody® therapeutics with a focus on novel targeted T-cell engagement.
Using our proprietary transgenic mouse platform, we have created a tumour-targeted T-cell engager mechanism capable of activating T-cells only in the tumour microenvironment. Our ability to configure unique therapeutic formats allows Humabodies to engage targets in ways that generates new biology through novel target engagement.
